Malcom Pye, CEO of Benchmark, a leading aquaculture technology company that supplies health, genetics and advanced nutrition technologies, put the impact of disease in aquaculture into perspective at the recent IntraFish Seafood Investor Forum in New York.

According to Pye, the estimated annual cost to the industry of sea lice is more than $500 million (€423.9 million), while the impact of pancreatic disease (PD) in Norway alone cost companies $250 million (€212 million).The estimated annual cost of Salmonid Rickettsial Septicaemia (SRS) to the industry is $300 million (€254.4